LC3-dependent extracellular vesicles (LDEVs) promote M-MDSC accumulation and immunosuppression in colorectal cancer.

For a long time, myeloid-derived suppressor cells (MDSCs) dilated in circulation system of CRC patients have been puzzling clinicians.Various evidence shows that MDSCs constitute the bulk of immunosuppression in CRC, which is related to tumor growth, adhesion, invasion, metastasis and immune escape. However, the mechanisms underlying these cells formation remain incompletely understood. In this study, we reported that CRC cell derived LDEVs mediated M-MDSCs formation via TLR2-MYD88 pathway.Furthermore Hsp60 was the LDEVs surface ligand that triggered these MDSCs induction. In clinical studies, we reported that accumulation of circulating M-MDSCs as well as IL-10 and arginase1 secretion were reliant upon to the levels of tumor cell derived LDEVs in CRC patients. These findings indicated how local tumor cell derived EVs influence distal hematopoiesis and provided novel justification for therapeutic targeting of LDEVs in patients with CRC.